OWC Pharmaceutical Research Corp. appointed Oron Zeevi as chief scientific officer.
Previously, Zeevi served as chief scientific officer at NeuroDerm Ltd., which was bought by Mitsubishi Tanabe Pharma Corp. for $1.1 billion in 2017.
OWC Pharmaceutical appoints chief scientific officer
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
OWC Pharmaceutical Research Corp. appointed Oron Zeevi as chief scientific officer.
Previously, Zeevi served as chief scientific officer at NeuroDerm Ltd., which was bought by Mitsubishi Tanabe Pharma Corp. for $1.1 billion in 2017.